Bluebird Bio Chief Financial Officer Resigns as Company Raises “Going Concern” Doubts

Human Gene Therapy,Volume 33, Issue 7-8, Page 351-354, April 2022.

Source: Human Gene Therapy - April 19, 2022 Category: Genetics & Stem Cells Authors: Alex Philippidis Source Type: research